These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A comparison of the efficacy and acceptability of fenfluramine tablets (BP) and prolonged action capsules. Innes JA; Campbell IW; Millar J; Munro JF Postgrad Med J; 1975; 51 Suppl 1():160-2. PubMed ID: 768961 [No Abstract] [Full Text] [Related]
4. Acceptability of prolonged release fenfluramine capsules in obese patients in general practice. Owen JH Postgrad Med J; 1975; 51 Suppl 1():176-7. PubMed ID: 768964 [No Abstract] [Full Text] [Related]
5. Prolonged-action fenfluramine in non-diabetic patients with refractory obesity. Galloway DB; Logie AW; Petrie JC Postgrad Med J; 1975; 51 Suppl 1():155-7. PubMed ID: 768957 [No Abstract] [Full Text] [Related]
6. [Clinical trial of a new long-acting fenfluramine in the treatment of obesity]. Pugnoli C; Bandini L; Caronna S; Ciarlini E; Magnati G; Strata A; Tirelli F G Clin Med; 1978 Nov; 59(11):486-510. PubMed ID: 369930 [No Abstract] [Full Text] [Related]
7. A clinical trial of a new fenfluramine preparation (Ponderax PA). Hooper AC Postgrad Med J; 1975; 51 Suppl 1():159-60. PubMed ID: 768960 [No Abstract] [Full Text] [Related]
8. Influence of a long acting preparation of fenfluramine on body weight, body composition and skinfold thickness in obese subjects. Balasse EO; Couturier E; Kornitzer M; Degre S Postgrad Med J; 1975; 51 Suppl 1():157. PubMed ID: 768958 [No Abstract] [Full Text] [Related]
9. [Treatment of obesity with fenfluramine (Ponderal) in general practice]. Schiøttz-Christensen E Ugeskr Laeger; 1979 Sep; 141(39):2660-2. PubMed ID: 394442 [No Abstract] [Full Text] [Related]
11. Comparison of fenfluramine and placebo on obese Nigerians. Lewis EA; Adeleye GI; Ukponmwan OO Niger Med J; 1978; 8(2):104-7. PubMed ID: 347827 [No Abstract] [Full Text] [Related]
12. Anorectic effectiveness of differing dosage forms of fenfluramine. Tisdale SA; Ervin DK Curr Ther Res Clin Exp; 1976 Jun; 19(6):589-94. PubMed ID: 819218 [No Abstract] [Full Text] [Related]
13. [Treatment of obesity with fenfluramine (Ponderal)]. Persson I; Andersen UD; Deckert T Ugeskr Laeger; 1973 Sep; 135(36):1932-7. PubMed ID: 4590075 [No Abstract] [Full Text] [Related]
14. Dexfenfluramine for obesity. Med Lett Drugs Ther; 1996 Jul; 38(979):64-5. PubMed ID: 8692074 [No Abstract] [Full Text] [Related]
15. [The therapeutic effect of Fenfluramine on body weight in overweight patients. A controlled clinical study]. Haug E; Myklebust R Tidsskr Nor Laegeforen; 1973 Dec; 93(35):2545-9. PubMed ID: 4589598 [No Abstract] [Full Text] [Related]
16. [Does fenfluramine mean a real advance in the treatment of obesity?]. Chruściel M; Chruściel TL Postepy Hig Med Dosw; 1973; 27(3):365-90. PubMed ID: 4198497 [No Abstract] [Full Text] [Related]
17. A collaborative investigation of fenfluramine. Anorexigenic with sedative properties. Elliott BW Curr Ther Res Clin Exp; 1970 Aug; 12(8):502-15. PubMed ID: 4988837 [No Abstract] [Full Text] [Related]
18. A controlled investigation of the "glycolyptic" action of fenfluramine. Garrow JS; Belton EA; Daniels A Lancet; 1972 Sep; 2(7777):559-61. PubMed ID: 4115737 [No Abstract] [Full Text] [Related]
19. Long-term efficacy of fenfluramine in treatment of obesity. Douglas JG; Gough J; Preston PG; Frazer I; Haslett C; Chalmers SR; Munro JF Lancet; 1983 Feb; 1(8321):384-6. PubMed ID: 6130379 [TBL] [Abstract][Full Text] [Related]
20. [The effect of Ponderal in patients with refractory overweight]. Myking O; Bassoe HH; Closs K Tidsskr Nor Laegeforen; 1973 Dec; 93(35):2541-5. PubMed ID: 4589597 [No Abstract] [Full Text] [Related] [Next] [New Search]